COVID-19 Testing & Analysis to Flatten the Curve

By Kiran Mazumdar Shaw India needs to promptly start epidemiological data collection and analysis to fine-tune its response to the COVID-19 outbreak, flatten the curve and avoid interventions that may turn out to be unnecessarily costly for the nation. Epidemiological data is very important as it can answer critical questions about how the virus is … Continue reading COVID-19 Testing & Analysis to Flatten the Curve

Post COVID-19 new economy will bring equilibrium

By: Kiran Mazumdar-Shaw, Biocon  In an exclusive video chat, with Shradha Sharma, Founder and Chief Editor of YourStory.com, Biocon CMD Kiran Mazumdar-Shaw talks about what founders can do to build for lasting value in the times of coronavirus. When asked in the interview on her advice to startups and small businesses that are getting badly affected … Continue reading Post COVID-19 new economy will bring equilibrium

India must scale up its testing rates by involving accredited private labs

Interview of Kiran Mazumdar Shaw with Sharan Poovanna from Live Mint In a recent interview with Mint, Kiran Mazumdar-Shaw, CMD Biocon Ltd. and member of the working group communicating with the government on dealing with the current crisis said, "With only five people per million being tested, India has one of the lowest coronavirus testing … Continue reading India must scale up its testing rates by involving accredited private labs

How to make India ready for future coronavirus-like crises

India must combine its infectious diseases data-mining prowess with advanced medical technologies. By: Kiran Mazumdar Shaw The coronavirus pandemic is a lesson that governments worldwide ignore research into infectious diseases at their own peril. The Covid-19 outbreak has taken the world completely unawares, exposing the vulnerability of public health systems in coping with infectious disease … Continue reading How to make India ready for future coronavirus-like crises